BIDMC Dermatology

The TIMI Study Group is an esteemed academic research organization affiliated with Brigham and Women's Hospital and Harvard Medical School, dedicated to advancing the understanding and treatment of cardiovascular disease since its establishment in 1984. With a diverse portfolio of over 80 trials conducted across 50 countries, the group focuses on innovative clinical trials that span phases I to IV, enrolling a vast range of subjects from those with risk factors to patients in acute care. Leveraging a comprehensive database of clinical findings, biomarkers, and genotypes, the TIMI Study Group plays a pivotal role in shaping cardiovascular medicine through large-scale international randomized controlled trials and sophisticated analyses. Celebrating its 40th anniversary in 2024, TIMI continues to lead transformative research that enhances patient care and improves outcomes for individuals suffering from cardiovascular conditions. Generated from the website